ANS is committed to advancing, fostering, and promoting the development and application of nuclear sciences and technologies to benefit society.
Explore the many uses for nuclear science and its impact on energy, the environment, healthcare, food, and more.
Explore membership for yourself or for your organization.
Conference Spotlight
Nuclear Energy Conference & Expo (NECX)
September 8–11, 2025
Atlanta, GA|Atlanta Marriott Marquis
Standards Program
The Standards Committee is responsible for the development and maintenance of voluntary consensus standards that address the design, analysis, and operation of components, systems, and facilities related to the application of nuclear science and technology. Find out What’s New, check out the Standards Store, or Get Involved today!
Latest Magazine Issues
Jul 2025
Jan 2025
Latest Journal Issues
Nuclear Science and Engineering
August 2025
Nuclear Technology
Fusion Science and Technology
Latest News
ANS joins others in seeking to discuss SNF/HLW impasse
The American Nuclear Society joined seven other organizations to send a letter to Energy Secretary Christopher Wright on July 8, asking to meet with him to discuss “the restoration of a highly functioning program to meet DOE’s legal responsibility to manage and dispose of the nation’s commercial and legacy defense spent nuclear fuel (SNF) and high-level radioactive waste (HLW).”
Technical Session|Panel|Sponsored by IRD
Monday, November 16, 2020|1:00–3:10PM EST
Session Chairs:
Lin-Wen Hu (MIT)
James Bowen (PNNL)
Session Organizer:
Staff Producer:
Rick Michal (American Nuclear Society)
Radioisotopes produced from nuclear reactors and accelerators are widely used for medical diagnostics and cancer therapy. For example, Tc-99m (decay product of Mo-99) is used in more than 80% of nuclear medicine diagnostic procedures. I-131 is widely used to treat thyroid cancer and applications of Lu-177 have increased in recent years for targeted therapy. This panel session will feature the following speakers to discuss the advancement and status of domestic production and applications of medical isotopes: 1) Peter J. Karcz: NNSA’s Mo-99 Program: Accelerating Reliable, Non-HEU Mo-99 Production Capabilities in the U.S., 2) Greg Piefer: Progress at SHINE Medical in Commercializing Mo-99 and Lu-177 for Diagnostic and Therapeutic Applications, 3) Ira Goldman: Achieving Security of Supply of Medical Radioisotopes, 4) Les Foyto: MURR’s Role in Supplying Isotopes for Research and Patient Care, and 5) Jon Neuhoff: DOE Production of Radioisotopes for Medical Research, Diagnosis, and Treatment
To access the session recording, you must be logged in and registered for the meeting.
Register NowLog In
To access session resources, you must be logged in and registered for the meeting.
To join the conversation, you must be logged in and registered for the meeting.